(MedPage Today) — The American Society of Clinical Oncology (ASCO) meeting featured major updates in multiple myeloma, including early data on trispecific antibodies and novel bispecific combinations, but the future of treatment will depend on…
Source link : https://www.medpagetoday.com/meetingcoverage/ascofuturefocusmm/116113
Author :
Publish date : 2025-06-17 15:29:00
Copyright for syndicated content belongs to the linked Source.
